Homocysteine and pro-inflammatory cytokine concentrations in acute heart disease

Cytokine

Volumn 50, Issue 1, 2010, Pages 15-18

  Gokkusu, Cahide ^a   Tulubas, Feti ^a   Unlucerci, Yesim ^a   Ozkok, Elif ^b   Umman, Berrin ^a   Aydin, Makbule ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Acute heart disease; Folate; Homocysteine; Interleukin; Vitamin B12

Indexed keywords

HOMOCYSTEINE; INTERLEUKIN 2; INTERLEUKIN 6;

ACUTE CORONARY SYNDROME; ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FOLIC ACID BLOOD LEVEL; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; DEMOGRAPHY; FOLIC ACID; HOMOCYSTEINE; HUMANS; INFLAMMATION; INTERLEUKIN-2; INTERLEUKIN-6; MIDDLE AGED; ROC CURVE; VITAMIN B 12;

EID: 77049111501     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2009.12.015     Document Type: Article

References (33)

1. Gori A.M., Corsi A.M., Fedi S., Gazzini A., Sofi F., Bartali B., et al. A proinflammatory state is associated with hyper-homocysteinemia in the elderly. Am J Clin Nutr 82 (2005) 335-341
2. McCarty M.F. Increased homocyst(e)ine associated with smoking, chronic inflammation, and aging may reflect acute-phase induction of pyridoxal phosphatase activity. Med Hypotheses 55 (2000) 289-293
3. Elkind M.S.V., Rundek T., Sciacca R.R., Ramas R., Chen H.J., and Boden-Albala B. Interleukin-2 levels are associated with carotid artery intima-media thickness. Atherosclerosis 180 (2005) 181-187
4. Frostegard F.J., Ulfgren A., Nyberg P., Hedin U., Swedenborg J., and Andersson U. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 145 (1999) 33-43
5. Simon D.D., Yazdani S., Wang W., and Schwartz A. Elevated plasma levels of interleukin-2 and soluble IL-2 receptor in ischemic heart disease. Clin Cardiol 24 (2001) 253-269
6. Wei M., Kuukasjarvi P., Laurikka J., Kaukinen S., Honkonen E.L., Metsanoja R., et al. Relation of cytokines to vasodilation after coronary artery bypass grafting. World J Surg 27 (2003) 1093-1098
7. Sawa Y., Ichikawa H., Kagisaki K., Ohata T., and Matsuda H. IL-6 derived from hypoxic myocytes promotes neutrophil-mediated reperfusion injury in myocardium. J Thorax Cardiovasc Surg 116 (1998) 511-517
8. Holven K.B., Aukurst P., Retterstol K., Havge T.A., Morkrid L., and Ose L. Increased levels of C reactive protein and interleukin-6 hyperhomocysteinemic subject. Scand J Clin Lab Invest 66 (2006) 45-54
9. Ridker P., Rifai N., Stampfer M.J., and Hennekens C.H. Plasma concentrations of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101 (2000) 1767-1772
10. Law W.M., and Morris J.K. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 325 (2002) 1202-1209
11. Kerkeni M., Addad F., Chauffert M., Chuniaud L., Miled A., Trivin F., et al. Hyperhomocysteinemia, paraoxonase activity and risk of coronary artery disease. Clin Biochem 39 (2006) 821-825
12. Refsum H., Ueland P.M., Nygard O., and Vollset S.E. Homocysteine and cardiovascular disease. Annu Rev Med 49 (1998) 3-62
13. Austin R.C., Lentz S.R., and Werstuck G.H. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease. Cell Death Differ 11 (2004) S56-S64
14. Chobanian A.V., Bakris G.L., Black H.R., et al. The National High Blood Pressure Education Program Coordinating Committee. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42 (2003) 1206-1252 (JNC 7: Complete Reports)
15. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 29 Suppl. 1 (2006) S43-S48
16. Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. National Cholesterol Education Program National Heart, Lung, and Blood Institute National Institutes of Health NIH Publication; 2002 [No. 02-5215].
17. Vester B., and Rasmussen K. High performance liquid chromatography method for rapid and accurate determination of homocysteine in plasma and serum. Eur J Clin Biochem 29 (1991) 549-554
18. Ubbink J.B., Vermaak W.H.J., and Bissbort S. Rapid high performance liquid chromatographic assay for total homocysteine levels in human serum. J Chromatogr 565 (1991) 441-446
19. Zweig M.H., and Campbell G. Receiver operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 39 (1993) 561-577
20. Wadwa R.P., Kinney G.L., Ogden L., Snell-Bergeon J.K., Maahs D.M., and Cornell E. Soluble interleukin-2 receptor as a marker for progression of coronary artery calcification in type 1 diabetes. Int J Biochem Cell Biol 38 (2006) 996-1003
21. Mazzone A., De Servi S., Vezzoli M., Fossati G., Mazzucchelli I., and Gritti D. Plasma levels of interleukin-2, 6, 10 and phenotypic characterization of circulating T lymphocytes in ischemic heart disease. Atherosclerosis 145 (1999) 369-374
22. Mizia-Stec K., Gasior Z., Zahorska-Markiewicz B., Janowska J., Szulc A., and Jastrzebska-Maj E. Serum tumour necrosis factor-alpha, interleukin-2 and interleukin-10 activation in stable angina, and acute coronary syndromes. Coron Artery Dis 14 (2003) 431-438
23. Matsumaru A., Yarmada T., Suzuki H., Matoba Y., and Sasayama S. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J 72 (1994) 561-566
24. Harris T.B., Ferrucci L., Tracy R.P., Corti M.C., Wacholder S., and Ettinger Jr. W.H. Association of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 106 (1999) 506-512
25. La Flamme A.C., and Pearce E.J. The absence of IL-6 does not affect Th2 cell development in vivo, but does lead to impaired proliferation, IL-2 receptor expression, and B cell responses. J Immunol 162 (1999) 5829-5837
26. Akira S., Taga T., and Kishimoto T. Interleukin-6 in biology and medicine. Adv Immunol 54 (1993) 1
27. Silvennoinnson O., and Ihne J.N. Biology and characterization of hematopoietic cytokines. Signaling by the hematopoietic cytokine receptors (1996), Chapman & Hall, New York 13
28. Woo K.S., Chook P., Lolin Y.I., et al. Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans. Circulation 96 (1997) 2542-2544
29. Clarke R., Daly L., Robinson K., et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 324 (1991) 1149-1155
30. Guo H., Chi J., Xing Y., and Wang P. Influence of folic acid on plasma homocysteine levels & arterial endothelial function in patients with unstable angina. Indian J Med Res 129 (2009) 279-284
31. Nevado J.B., and Imasa M.S. Homocysteine predicts adverse clinical outcomes in unstable angina and non-ST elevation myocardial infarction: implications from the folate intervention in non-ST elevation myocardial infarction and unstable angina study. Coron Artery Dis 19 (2008) 153-161
32. Papatheodorou L., and Weiss N. Vascular oxidant stress and inflammation in hyperhomocysteinemia. Antioxid Redox Signal 9 (2007) 1941-1958
33. Lee K.W., Hill J.D., Walley K.R., and Frohlich J.J. Relative value of multiple plasma biomarkers as risk factors for coronary artery disease and death in an angiography cohort. CMAJ 174 (2006) 461-466